ATE188119T1 - Heilmittel für wunden und hämorrhoiden - Google Patents
Heilmittel für wunden und hämorrhoidenInfo
- Publication number
- ATE188119T1 ATE188119T1 AT93903319T AT93903319T ATE188119T1 AT E188119 T1 ATE188119 T1 AT E188119T1 AT 93903319 T AT93903319 T AT 93903319T AT 93903319 T AT93903319 T AT 93903319T AT E188119 T1 ATE188119 T1 AT E188119T1
- Authority
- AT
- Austria
- Prior art keywords
- wounds
- hemorrhoids
- remedies
- prostaglandin
- derivatives
- Prior art date
Links
- 206010052428 Wound Diseases 0.000 title abstract 3
- 208000027418 Wounds and injury Diseases 0.000 title abstract 3
- 208000014617 hemorrhoid Diseases 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 abstract 1
- LMHIPJMTZHDKEW-XQYLJSSYSA-M Epoprostenol sodium Chemical compound [Na+].O1\C(=C/CCCC([O-])=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 LMHIPJMTZHDKEW-XQYLJSSYSA-M 0.000 abstract 1
- 229960000711 alprostadil Drugs 0.000 abstract 1
- 229960001123 epoprostenol Drugs 0.000 abstract 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- 150000003174 prostaglandin I2 derivatives Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2280892 | 1992-02-07 | ||
| JP18986792 | 1992-06-24 | ||
| PCT/JP1993/000151 WO1993015739A1 (fr) | 1992-02-07 | 1993-02-05 | Remede destine aux blessures ou aux hemorroides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE188119T1 true ATE188119T1 (de) | 2000-01-15 |
Family
ID=26360087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93903319T ATE188119T1 (de) | 1992-02-07 | 1993-02-05 | Heilmittel für wunden und hämorrhoiden |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US5403867A (OSRAM) |
| EP (1) | EP0583482B1 (OSRAM) |
| JP (1) | JP3209427B2 (OSRAM) |
| AT (1) | ATE188119T1 (OSRAM) |
| CA (1) | CA2107669C (OSRAM) |
| DE (1) | DE69327432T2 (OSRAM) |
| TW (1) | TW234691B (OSRAM) |
| WO (1) | WO1993015739A1 (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
| US5403867A (en) * | 1992-02-07 | 1995-04-04 | Kaken Pharmaceutical Co., Ltd. | Preparation for treating wounds or hemorrhoids |
| EP0731712A4 (en) * | 1993-10-29 | 2005-11-09 | Univ Boston | PHYSIOLOGICALLY STABLE COMPOSITIONS OF BUTYRIC ACID, SALTS AND BUTYRIC ACID DERIVATIVES AS ANTINEOPLASTIC AGENTS |
| US6190691B1 (en) | 1994-04-12 | 2001-02-20 | Adolor Corporation | Methods for treating inflammatory conditions |
| US5962477A (en) * | 1994-04-12 | 1999-10-05 | Adolor Corporation | Screening methods for cytokine inhibitors |
| IT1269634B (it) * | 1994-05-06 | 1997-04-08 | Indena Spa | Medicamento topico ad attivita' cicatrizzante |
| WO1995033465A1 (en) * | 1994-06-02 | 1995-12-14 | Teijin Limited | Pharmaceutical composition for treating peripheral circulation disorder |
| CA2181364A1 (en) * | 1994-11-17 | 1996-05-30 | Kaneto Uekama | Preparation for percutaneous absorption |
| CA2188931C (en) * | 1995-02-27 | 2007-09-11 | Reiji Kasukawa | Agent for treating cor pulmonale |
| US5849761A (en) | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
| US6573282B1 (en) | 1995-09-12 | 2003-06-03 | Adolor Corporation | Peripherally active anti-hyperalgesic opiates |
| US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
| US5869059A (en) * | 1996-01-16 | 1999-02-09 | Mon's Tea Partnership | Herbal composition for hemorrhoid treatment |
| AU774861B2 (en) * | 1998-02-11 | 2004-07-08 | Douglas V Faller | Compositions and methods for the treatment of cystic fibrosis |
| US6365198B1 (en) * | 2001-01-28 | 2002-04-02 | Gulf Pharmaceutical Industries | Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids |
| US20040266880A1 (en) * | 2002-02-22 | 2004-12-30 | Fumie Sato | Antipruritics |
| MXPA04004371A (es) * | 2002-08-09 | 2004-08-13 | Taisho Pharmaceutical Co Ltd | Agente antipruritico. |
| US7737182B2 (en) * | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
| JP2006522136A (ja) * | 2003-04-02 | 2006-09-28 | ネックスメド ホールディングス インコーポレイテッド | プロスタグランジン組成物および血管痙攣の治療のためのその使用 |
| JP4157889B2 (ja) * | 2003-06-25 | 2008-10-01 | 有限会社 循環器研究所 | 性交機能改善用外用製剤 |
| GB0524103D0 (en) * | 2005-11-26 | 2006-01-04 | Medical Res Council | Healing |
| WO2010105112A1 (en) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Detection of short-chain fatty acids in biological samples |
| US20110086869A1 (en) | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
| CN102802412A (zh) | 2009-12-08 | 2012-11-28 | 海玛奎斯特医药公司 | 用于治疗红细胞病症的方法及低剂量方案 |
| WO2011113013A2 (en) | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
| US8940794B2 (en) | 2011-04-07 | 2015-01-27 | Nexmed Holdings, Inc. | Methods and compositions for treating Raynaud's disease |
| WO2014164886A1 (en) * | 2013-03-13 | 2014-10-09 | Allergan, Inc. | Prostanoid receptor agonist compounds and their use |
| GB2567093A (en) | 2016-07-15 | 2019-04-03 | Viracta Therapeutics Inc | Histone deacetylase inhibitors for use in immunotherapy |
| US20220226322A1 (en) | 2019-05-31 | 2022-07-21 | Viracta Subsidiary, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK142235B (da) * | 1974-12-20 | 1980-09-29 | Yamanouchi Pharma Co Ltd | Analogifremgangsmåde til fremstilling af 20-alkoxy-16-methyl-prostadiensyre-derivater. |
| US4025645A (en) * | 1976-01-27 | 1977-05-24 | Jelenko Iii Carl | Non-steroid topical agent for alleviating inflammation in mammals |
| GB1595056A (en) * | 1976-10-12 | 1981-08-05 | Wellcome Found | Pharmaceutical combination |
| JPS5391110A (en) * | 1977-01-20 | 1978-08-10 | Yamanouchi Pharmaceut Co Ltd | Novel drug composition for rectal infusion |
| US4260603A (en) * | 1979-01-02 | 1981-04-07 | Pegel Karl H | Sterol glycoside with activity as prostaglandin synthetase inhibitor |
| DE3162659D1 (en) * | 1980-07-22 | 1984-04-19 | Ono Pharmaceutical Co | 9,11-methano-13-aza-11a-carbathrombanoic acid analogues and pharmaceutical use thereof |
| DE3631169A1 (de) * | 1986-09-11 | 1988-03-24 | Schering Ag | Prostacyclinderivate enthaltende mittel fuer die topische anwendung |
| EP0365678B1 (en) * | 1987-10-16 | 1994-01-05 | Toray Industries, Inc. | 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF |
| JPH0311017A (ja) * | 1989-06-06 | 1991-01-18 | Green Cross Corp:The | プロスタグランジンｅ↓１含有薬剤組成物 |
| DE69213057T2 (de) * | 1991-03-14 | 1997-01-09 | Ueno Seiyaku Oyo Kenkyujo Kk | Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen |
| US5403867A (en) * | 1992-02-07 | 1995-04-04 | Kaken Pharmaceutical Co., Ltd. | Preparation for treating wounds or hemorrhoids |
| WO1994017806A1 (fr) * | 1993-02-03 | 1994-08-18 | Teijin Limited | Composition de preparation dermatologique contenant de la prostacycline comme principe actif |
-
1993
- 1993-02-05 US US08/129,157 patent/US5403867A/en not_active Expired - Lifetime
- 1993-02-05 EP EP93903319A patent/EP0583482B1/en not_active Expired - Lifetime
- 1993-02-05 AT AT93903319T patent/ATE188119T1/de not_active IP Right Cessation
- 1993-02-05 JP JP51394793A patent/JP3209427B2/ja not_active Expired - Fee Related
- 1993-02-05 CA CA002107669A patent/CA2107669C/en not_active Expired - Fee Related
- 1993-02-05 WO PCT/JP1993/000151 patent/WO1993015739A1/ja not_active Ceased
- 1993-02-05 DE DE69327432T patent/DE69327432T2/de not_active Expired - Fee Related
- 1993-03-09 TW TW082101725A patent/TW234691B/zh active
-
1994
- 1994-12-27 US US08/365,516 patent/US5679707A/en not_active Expired - Lifetime
-
1997
- 1997-07-09 US US08/890,443 patent/US5852050A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5403867A (en) | 1995-04-04 |
| DE69327432T2 (de) | 2000-05-18 |
| US5679707A (en) | 1997-10-21 |
| TW234691B (OSRAM) | 1994-11-21 |
| US5852050A (en) | 1998-12-22 |
| EP0583482A4 (en) | 1995-05-03 |
| CA2107669C (en) | 2004-06-01 |
| JP3209427B2 (ja) | 2001-09-17 |
| DE69327432D1 (de) | 2000-02-03 |
| EP0583482B1 (en) | 1999-12-29 |
| CA2107669A1 (en) | 1993-08-08 |
| EP0583482A1 (en) | 1994-02-23 |
| WO1993015739A1 (fr) | 1993-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE188119T1 (de) | Heilmittel für wunden und hämorrhoiden | |
| AU549481B2 (en) | Hair growing agent | |
| EP0427247A3 (en) | Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient | |
| GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
| ES2159591T3 (es) | Composicion de liberacion controlada. | |
| EE02971B1 (et) | Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks | |
| PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
| ES2055860T3 (es) | Derivados 2-aminopirimidinona. | |
| NO171365C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| FI870457A0 (fi) | Farmaceutiska preparatformer foer stabilisering av interferon- . | |
| ATE173627T1 (de) | Medizinische zusammensetzung | |
| RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
| DE69004532D1 (de) | Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen. | |
| ATE80616T1 (de) | Prostaglandin e1-derivate und ihre therapeutische anwendung. | |
| ITRM910730A1 (it) | Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali. | |
| BR9913982A (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares | |
| AU3401093A (en) | Therapeutic agent for threatened abortion | |
| DE69024060D1 (de) | Osteogenesis-stimulierende mittel. | |
| ES2032476T3 (es) | Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina. | |
| HK8994A (en) | Medicament for treatment of pregnancy-induced hypertension | |
| ES2124926T3 (es) | Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas. | |
| EP0729950A4 (en) | ANTI-HIV MEDICINAL PRODUCTS | |
| UA12937A (uk) | Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом | |
| AU4246189A (en) | Medicament for the treatment of diseases caused by retroviruses | |
| TH20329A (th) | สิ่งป้องกันโรคและสิ่งหรือยาใช้รักษาโรคสำหรับบาดแผล และ/หรือการอักเสบซึ่งเกี่ยวกับตา |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |